Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Thrombocytosis × luspatercept × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myeloproliferative Disorders 3 Myelodysplastic Syndromes 2 Anemia 2 Thrombocytosis 1 Primary Myelofibrosis 1 Leukemia, Myeloid, Acute 1

Interventions

Specimen Handling 2 Biopsy 2 peginterferon alfa-2b 1 luspatercept 1 itacitinib 1 N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1 INCB039110 1 Hydroxyurea 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05005182 2024-09-19

Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms With Ring Sideroblasts and Thrombocytosis or Unclassifiable With Ring Sideroblasts

Mayo Clinic

Phase 2 Terminated

3 enrolled 12 charts

Myeloproliferative Disorders, Thrombocytosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡